Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 03:00 ET | Source: FoRx Therapeutics AG

FoRx Therapeutics Presents Preclinical Data at ACS Spring 2026, Confirming FORX-428's Potential for Best-in-Class PARG Inhibition

Presentation of the molecular structure, discovery, and preclinical data supporting the potential best-in-class profile of PARG inhibitor FORX-428.